PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

Psychedelics Today
26/08/2022 1h 18min
PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

Listen "PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.  www.psychedelicstoday.com

More episodes of the podcast Psychedelics Today

PT 640 - Alexander Beiner - Psychedelics, Culture, and the Games We Play 25/11/2025
PT 639 - Evelyn Eddy Shoop PMHNP-BC: Lived Experience, Qualitative Data, and the Future of Psychedelic Care 21/11/2025
PT 638 - Dr Jason Konner - Psychedelic Oncologist 18/11/2025
PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration 11/11/2025
PT 636 - Dr. Ros Watts – Building Communities and Connection 04/11/2025
PT 635 - Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher 28/10/2025
PT 634 - Brad Adams - LAMPS 21/10/2025
PT 633 - Dreamshadow - Life and Breath 15/10/2025
PT 632 - Megan Portnoy MS - Ontological Design, Psychedelic Spaces, and Integrating Rigor 14/10/2025
PT 631 - Kyle Buller and Joe Moore - Breathwork, Community, Bodywork and more! 10/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA